doi: 10.3389/fnut.2025.1676080 Received 01 August 2025 Accepted 10 September 2025 Published 04 December 2025 Volume 12 - 2025 Edited by Lidia Daimiel, IMDEA Food Institute, Spain Reviewed by Juan Gerardo Reyes-Garca, Escuela Superior de Medicina (IPN), Mexico Sergio Adrin Terrasa, Italian Hospital of Buenos Aires, Argentina Updates Copyright 2025 Wirnitzer, Motevalli, Tanous, Drenowatz, Moser, Cramer, Rosemann, Wagner, Michalsen, Knechtle, Fras, Ritskes-Hoitinga, Marques, Mis, Stanford, Schubert, Goswami, Leitzmann, Fredriksen, Ruedl, Wilflingseder, Lima, Kessler, Jeitler, Khan, Joulaei, Fatemi, Knight, Kratky, Palmer, Haditsch, Jakse, Kofler, Pfeiffer, Cordova-Pozo, Tortella, Straub, Lynch, Schtzer, Krishnan, Fathima A., Gatterer, Kriwan, Abhishek, Nandgaonkar, Nandgaonkar, Adedara, Haro, Gericke, Neumann, Akhtar, Rashidlamir, Thangavelu, Ngoumou, Perpk, Klaper, Bhattacharya, Kirschner, Bessems, Jones, Peoples, Bescos, Duftner and Seifert
It supports a healthy skin barrier
Tirzepatide alone achieves 20.9% weight loss in SURMOUNT-1, which approaches or matches what phentermine-plus-semaglutide combinations achieve in observational data
But can endogenous GLP-1, meaning GLP-1 from-within-the-body, work as an alternative to the drugs that mimic GLP-1, like Ozempic
The compound was prepared according to the procedure described in Example 1, with the exception that 85.2 mg (0.70 mmol) TRIS was used
Analyses of bovine luteal fractions obtained by FACS reveals enrichment of miR-183-96-182 cluster miRNAs in endothelial cells